Filtered By:
Source: Oncology Reports
Drug: Lovastatin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
In conclusion, our data suggest that MCM2 may be a novel therapeutic target of lovastatin treatment in NSCLCs.
PMID: 25738322 [PubMed - as supplied by publisher]
Source: Oncology Reports - March 5, 2015 Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
